Journal of Molecular Endocrinology, 25(3), 287298
MOTS-c activates AMPK to shift cellular metabolism toward fat oxidation and improve insulin sensitivity, while 5-Amino-1MQ inhibits NNMT to preserve NAD+ availability and enhance mitochondrial function
Earlier this month, the Food and Drug Administration expanded the approval for Xolair for certain kids and adults with food allergies, based on the results of the clinical trial
While both agents ultimately reduce adipose tissue volume in animal models, their mechanisms of action are distinct, representing the difference between metabolic acceleration and structural ablation
At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Penetrating muscle tissue is painful, and you might also hit a nerve by accident